Wockhardt moves HC against ban on its fixed dose combination drug

Wockhardt moved the court as its anti-inflammatory drug -- Ace Proxyvon -- is one of the FDC medicines affected by the Centre's September 7 notification banning 328 such combinations
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news